BIBRINA
Live / Applied — Fourth extension granted (statement of use) (as of 30 Mar 2026)
What this means for you
Not registered yet, but its 09 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97747050
- Mark type
- Stylized text
- Filed
- 09 Jan 2023
- Published for opposition
- 05 Mar 2024
- Attorney of record
- Phillip Barengolts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for humans for treatment of gynecological related diseases, disorders and deficiencies; pharmaceutical preparations for humans for treatment of hormone related diseases, disorders and deficiencies; pharmaceutical preparations for humans for treatment of cardiological related diseases, disorders and deficiencies; pharmaceutical preparations for humans for treatment of oncological related diseases, disorders and deficiencies
Owner
- Bayer Aktiengesellschaft, Leverkusen, DE
- Bayer Aktiengesellschaft, Leverkusen, DE
Prosecution history
- 31 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Mar 2026 — SOU EXTENSION 4 GRANTED
- 30 Mar 2026 — SOU EXTENSION 4 FILED
- 30 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Oct 2025 — SOU EXTENSION 3 GRANTED
- 28 Oct 2025 — SOU EXTENSION 3 FILED
- 28 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2025 — SOU EXTENSION 2 GRANTED
- 17 Mar 2025 — SOU EXTENSION 2 FILED
- 17 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED